HCA HEALTHCARE INC (HCA) Forecast, Price Target & Analyst Ratings

NYSE:HCA • US40412C1018

Current stock price

474.75 USD
+1.51 (+0.32%)
At close:
474.75 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HCA HEALTHCARE INC (HCA).

Forecast Snapshot

Consensus Price Target

Price Target
$551.68
+ 16.21% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 24, 2026
Period
Q1 / 2026
EPS Estimate
$7.24
Revenue Estimate
19.277B
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
74.84%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$551.68
Upside
+ 16.21%
From current price of $474.75 to mean target of $551.68, Based on 31 analyst forecasts
Low
$376.94
Median
$569.16
High
$666.75

Price Target Revisions

1 Month
1.02%
3 Months
12.54%

Price Target Summary

31 Wall Street analysts provided a forecast for the next 12 months for HCA. The average price target is 551.68 USD. This implies a price increase of 16.21% is expected in the next year compared to the current price of 474.75.
The average price target has been revised upward by 12.54% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

HCA Current Analyst RatingHCA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

HCA Historical Analyst RatingsHCA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 10 20 30

Analyst Ratings Consensus

ChartMill Buy Consensus
74.84%
HCA was analyzed by 31 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about HCA.
In the previous month the buy percentage consensus was at a similar level.
HCA was analyzed by 31 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-10TD CowenMaintains Buy -> Buy
2026-02-25MizuhoMaintains Outperform -> Outperform
2026-02-23UBSMaintains Buy -> Buy
2026-02-20JP MorganMaintains Neutral -> Neutral
2026-02-06Argus ResearchMaintains Buy -> Buy
2026-01-30Wells FargoMaintains Equal-Weight -> Equal-Weight
2026-01-28Cantor FitzgeraldMaintains Overweight -> Overweight
2026-01-28UBSMaintains Buy -> Buy
2026-01-28Deutsche BankMaintains Buy -> Buy
2026-01-28KeybancMaintains Overweight -> Overweight
2026-01-28OppenheimerMaintains Outperform -> Outperform
2026-01-28RBC CapitalMaintains Outperform -> Outperform
2026-01-28BarclaysMaintains Overweight -> Overweight
2026-01-28Truist SecuritiesMaintains Buy -> Buy
2026-01-28JefferiesMaintains Buy -> Buy
2026-01-07Wells FargoMaintains Equal-Weight -> Equal-Weight
2025-12-18MizuhoMaintains Outperform -> Outperform
2025-12-15Morgan StanleyDowngrade Equal-Weight -> Underweight
2025-11-13Wells FargoMaintains Equal-Weight -> Equal-Weight
2025-10-28JefferiesMaintains Buy -> Buy
2025-10-27TD CowenMaintains Buy -> Buy
2025-10-27MizuhoMaintains Outperform -> Outperform
2025-10-27UBSMaintains Buy -> Buy
2025-10-27KeybancMaintains Overweight -> Overweight
2025-10-27OppenheimerMaintains Outperform -> Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 24, 2026
Period
Q1 / 2026
EPS Estimate
$7.24
Revenue Estimate
19.277B
Revenue Q2Q
5.22%
EPS Q2Q
12.30%
Number of Analysts
22

Next Earnings Revisions

Revenue (1 Month)
0.01%
Revenue (3 Months)
-0.53%
EPS (1 Month)
-0.35%
EPS (3 Months)
0.58%

Next Earnings Summary

HCA is expected to report earnings on 4/24/2026. The consensus EPS estimate for the next earnings is 7.24 USD and the consensus revenue estimate is 19.28B USD.
The next earnings revenue estimate has been revised downward by 0.53% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
HCA revenue by date.HCA revenue by date.
64.968B
7.86%		70.603B
8.67%		75.6B
7.08%		79.43B
5.07%		83.324B
4.90%		88.119B
5.75%		93.772B
6.42%		99.903B
6.54%		102.844B
2.94%		107.505B
4.53%		112.383B
4.54%
EBITDA
YoY % growth
HCA ebitda by date.HCA ebitda by date.
12.704B
5.67%		13.859B
9.09%		15.488B
11.75%		16.16B
4.34%		16.928B
4.75%		17.869B
5.56%		18.959B
6.10%		20.097B
6.00%		21.027B
4.63%		21.981B
4.54%		22.972B
4.51%
EBIT
YoY % growth
HCA ebit by date.HCA ebit by date.
9.627B
6.34%		10.547B
9.56%		11.965B
13.44%		12.462B
4.15%		13.02B
4.48%		13.7B
5.22%		14.765B
7.77%		15.722B
6.48%		16.296B
3.65%		17.035B
4.53%		17.803B
4.51%
Operating Margin
HCA operating margin by date.HCA operating margin by date.
14.82%14.94%15.83%15.69%15.63%15.55%15.75%15.74%15.85%15.85%15.84%
EPS
YoY % growth
HCA eps by date.HCA eps by date.
18.66
10.41%		22.12
18.54%		28.38
28.30%		30.53
7.58%		33.67
10.28%		37.98
12.80%		43.67
14.97%		50.83
16.40%		60.18
18.39%		68.64
14.07%		78.36
14.16%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		7.24
12.30%		7.54
10.40%		7.34
5.43%		8.39
3.13%		8.06
11.26%		8.31
10.14%		8.00
8.96%		9.37
11.67%		8.80
9.17%		9.21
10.85%		8.30
3.78%		10.11
7.85%
Revenue
Q2Q % growth		19.277B
5.22%		19.516B
4.90%		19.964B
4.19%		20.497B
5.04%		20.23B
4.94%		20.456B
4.82%		20.924B
4.81%		21.452B
4.66%		21.166B
4.63%		21.538B
5.29%		21.934B
4.83%		22.752B
6.06%
EBITDA
Q2Q % growth		3.912B
5.30%		4.009B
-14.52%		3.939B
-29.37%		4.259B
-36.44%		4.129B
5.55%		4.201B
4.79%		4.127B
4.77%		4.493B
5.49%		4.268B
3.37%		4.449B
5.90%		4.128B
0.02%		4.839B
7.70%
EBIT
Q2Q % growth		3B
5.08%		3.082B
3.88%		3.015B
1.69%		3.305B
4.00%		3.191B
6.37%		3.232B
4.87%		3.132B
3.88%		3.487B
5.51%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

HCA Yearly Revenue VS EstimatesHCA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B 80B 100B
HCA Yearly EPS VS EstimatesHCA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20 40 60

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
10.20%
EPS Next 5 Year
12.36%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
4.82%
Revenue Next 5 Year
5.48%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
13.94%
EBIT Next 5 Year
10.71%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

HCA HEALTHCARE INC / HCA Forecast FAQ

What is the price target for HCA stock?

31 analysts have analysed HCA and the average price target is 551.68 USD. This implies a price increase of 16.21% is expected in the next year compared to the current price of 474.75.

When does HCA HEALTHCARE INC (HCA) report earnings?

HCA HEALTHCARE INC (HCA) will report earnings on 2026-04-24, before the market open.

Can you provide the consensus estimates for HCA HEALTHCARE INC next earnings?

The consensus EPS estimate for the next earnings of HCA HEALTHCARE INC (HCA) is 7.24 USD and the consensus revenue estimate is 19.28B USD.

What is the number of analysts for HCA stock?

The number of analysts covering HCA HEALTHCARE INC (HCA) is 31.